Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic
Date
2021-12
Journal Title
Journal ISSN
Volume Title
Publisher
Wolters Kluwer
Abstract
The human coronavirus disease 2019 (COVID‑19) pandemic has affected overall healthcare delivery, including prenatal, antenatal
and postnatal care. Hyperglycemia in pregnancy (HIP) is the most common medical condition encountered during pregnancy. There
is little guidance for primary care physicians for providing delivery of optimal perinatal care while minimizing the risk of COVID‑19
infection in pregnant women. This review aims to describe pragmatic modifications in the screening, detection and management
of HIP during the COVID‑ 19 pandemic. In this review, articles published up to June 2021 were searched on multiple databases,
including PubMed, Medline, EMBASE and ScienceDirect. Direct online searches were conducted to identify national and international
guidelines. Search criteria included terms to extract articles describing HIP with and/or without COVID‑19 between 1st March 2020
and 15th June 2021. Fasting plasma glucose, glycosylated hemoglobin (HbA1c) and random plasma glucose could be alternative
screening strategies for gestational diabetes mellitus screening (at 24–28 weeks of gestation), instead of the traditional 2 h oral
glucose tolerance test. The use of telemedicine for the management of HIP is recommended. Hospital visits should be scheduled
to coincide with obstetric and ultrasound visits. COVID‑19 infected pregnant women with HIP need enhanced maternal and fetal
vigilance, optimal diabetes care and psychological support in addition to supportive measures. This article presents pragmatic
options and approaches for primary care physicians, diabetes care providers and obstetricians for GDM screening, diagnosis and
management during the pandemic, to be used in conjunction with routine antenatal care.
Description
CITATION: Priya G, Bajaj S, Kalra B, Coetzee A, Kalra S, Dutta D, et al. Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic. J Family Med Prim Care 2021;10:4350-63. doi.10.4103/jfmpc.jfmpc_653_21
The original publication is available at: lww.com
The original publication is available at: lww.com
Keywords
Covid‑19, Diabetes in pregnancy, Hyperglycemia, Pregnancy -- Complications, COVID-19 (Disease), Pregnancy
Citation
Priya G, Bajaj S, Kalra B, Coetzee A, Kalra S, Dutta D, et al. Clinical practice recommendations for the detection and management of hyperglycemia in pregnancy from South Asia, Africa and Mexico during COVID‑19 pandemic. J Family Med Prim Care 2021;10:4350-63. doi.10.4103/jfmpc.jfmpc_653_21